×
0 0 0 0 0 0 -0.0115384615384616 -0.0167307692307692
Stock impact report

Ovid Therapeutics Reports Third Quarter 2019 Financial Results and Recent Progress

Ovid Therapeutics, Inc (OVID)  More Company Research Source: GlobeNewswire
Last ovid therapeutics, inc earnings: 8/7 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com
PDF Announced Positive Initial Results from the Ongoing ENDYMION trial with OV935 (Soticlestat) in Rare Epilepsies; Sustained and Progressively-Improving Median Seizure Frequency Reduction with Prolonged Treatment in Difficult-to-Treat Patient Population Strengthened Financial Position with the Completion of a Public Equity Offering Raising Approximately $33.7 Million in Net Proceeds Expects Four Clinical Data Readouts Across Pipeline in 2020 Including Topline Results from Pivotal Phase 3 NEPTUNE Trial in Angelman Syndrome NEW YORK, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today reported financial results for the third quarter ended September 30, 2019 and provided an overview of the company’s recent progress. “2020 is poised to be a transformational year for Ovid. We expect multiple clinical trial data readouts across our p [Read more]
Impact snapshot Event time: OVID
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
OVID alerts
from News Quantified
Opt-in for
OVID alerts

from News Quantified
Opt-in for
OVID alerts

from News Quantified